In a recent news piece, Massachusetts General Hospital (MGH) chose to highlight Cure Alzheimer's Fund's support of research through the lab of Dr. Rudy Tanzi.
MGH praises the venture capital approach taken by CAF co-founders Jeff and Jacqui Morby, enabling researchers like Tanzi to take risks and pursue "paradigm changing" studies. And the risks have paid off: According to MGH, the scientific results brought about by CAF-funded research are "nothing short of game changing, as Mass General researchers resolve some long-unanswered questions about how Alzheimer’s disease develops."
Cure Alzheimer's Fund Chairman and Co-Founder Jeff Morby and Co-Founder Jacqui Morby were featured for their support of Alzheimer's research in Sunday's Pittsburgh Post-Gazette. The article highlights Cure Alzheimer's Fund's success and the commitment of its founders and board to cover all operating costs. The Post-Gazette also describes the origins of the fund, which started off under the Pittsburgh Foundation until the Morbys garnered enough support to launch a public charity.
Ten years ago, our founders started Cure Alzheimer's Fund out of frustration with the slow pace and limited funding of research. Since then, we've funded dozens of ground-breaking studies that have enhanced our understanding of Alzheimer's disease and brought us closer to a cure.
On May 18 Jeff Morby, chairman and co-founder of Cure Alzheimer’s Fund, was honored with the prestigious Paul Harris Award from Rotary District 7950. Paul Harris founded the Rotary Club more than a century ago and the award was created to recognize those who have made great contributions to society under the Rotary’s motto of “Service Above Self.”
Henry McCance, chairman emeritus of Greylock Partners, co-founded Cure Alzheimer’s Fund (CAF) in 2005 after getting frustrated with the lack of knowledge about the disease when his wife was diagnosed. He was interviewed by the Boston Business Journal about his venture capital approach to funding Alzheimer's disease research.